Hikma Gears Up To Enter US Biosimilars Market With Ustekinumab Nod

Bio-Thera-Partnered Starjemza Becomes Eighth Stelara Rival To Be Approved By FDA

 
• By Dave Wallace
  
Hikma will have one of eight approved Stelara biosimilars (Shutterstock)

More from Biosimilars

More from Business